{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "the-right", "type": "clause", "offset": [17, 26]}, {"key": "on-behalf-of", "type": "clause", "offset": [28, 40]}, {"key": "health-care", "type": "clause", "offset": [58, 69]}, {"key": "other-non", "type": "clause", "offset": [126, 135]}, {"key": "research-institutions", "type": "definition", "offset": [143, 164]}, {"key": "to-practice", "type": "clause", "offset": [166, 177]}, {"key": "the-licensed-patent", "type": "clause", "offset": [178, 197]}, {"key": "any-non", "type": "clause", "offset": [221, 228]}, {"key": "sponsored-research", "type": "clause", "offset": [255, 273]}, {"key": "other-provision-of-this-agreement", "type": "clause", "offset": [333, 366]}, {"key": "no-right-to-enforce", "type": "clause", "offset": [375, 394]}, {"key": "other-institution", "type": "definition", "offset": [467, 484]}, {"key": "right-to-publish", "type": "clause", "offset": [494, 510]}, {"key": "information-included", "type": "clause", "offset": [515, 535]}, {"key": "the-technology", "type": "definition", "offset": [539, 553]}], "snippet": "Stanford retains the right, on behalf of itself, Stanford Health Care, \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Children\u2019s Hospital at Stanford and all other non-profit research institutions, to practice the Licensed Patent and use Technology for any non-profit purpose, including sponsored research and collaborations. ***** agrees that, notwithstanding any other provision of this Agreement, it has no right to enforce the Licensed Patent against any such institution. Stanford and any such other institution have the right to publish any information included in the Technology or a Licensed Patent.", "size": 69, "samples": [{"hash": "23ydfYqgUk3", "uri": "/contracts/23ydfYqgUk3#retained-rights", "label": "Exclusive License Agreement", "score": 27.332649231, "published": true}, {"hash": "4LdEvxIpwio", "uri": "/contracts/4LdEvxIpwio#retained-rights", "label": "Exclusive License Agreement", "score": 26.3552360535, "published": true}, {"hash": "hyOGUzkheUr", "uri": "/contracts/hyOGUzkheUr#retained-rights", "label": "Exclusive License Agreement", "score": 26.1704311371, "published": true}], "hash": "456bf4f03ebc4a2f5fc4d0606282f8fc", "id": 1}, {"snippet_links": [{"key": "the-contributor", "type": "clause", "offset": [0, 15]}, {"key": "if-applicable", "type": "definition", "offset": [20, 33]}, {"key": "in-addition-to", "type": "clause", "offset": [94, 108]}, {"key": "patent-rights", "type": "definition", "offset": [128, 141]}, {"key": "the-contribution", "type": "clause", "offset": [207, 223]}], "snippet": "The Contributor or, if applicable, the Contributor\u2019s Employer, retains all proprietary rights in addition to copyright, such as patent rights in any process, procedure or article of manufacture described in the Contribution.", "size": 65, "samples": [{"hash": "lvrQAr1hpWM", "uri": "/contracts/lvrQAr1hpWM#retained-rights", "label": "Open Access Agreement", "score": 20.2073917389, "published": true}, {"hash": "lgwEdVs8AV6", "uri": "/contracts/lgwEdVs8AV6#retained-rights", "label": "Open Access Agreement", "score": 20.2073917389, "published": true}, {"hash": "l6JHbMuE0Gl", "uri": "/contracts/l6JHbMuE0Gl#retained-rights", "label": "Open Access Agreement", "score": 20.2073917389, "published": true}], "hash": "bb687ecb18f59e6f01dc5d51e54c5619", "id": 2}, {"snippet_links": [{"key": "nothing-in-this-agreement", "type": "clause", "offset": [0, 25]}, {"key": "either-party", "type": "clause", "offset": [66, 78]}, {"key": "research-and-development", "type": "clause", "offset": [90, 114]}, {"key": "market-products", "type": "definition", "offset": [122, 137]}, {"key": "such-party", "type": "clause", "offset": [144, 154]}], "snippet": "Nothing in this Agreement shall limit in any respect the right of either Party to conduct research and development and to market products using such Party's technology other than as herein expressly provided.", "size": 48, "samples": [{"hash": "43kgP0iVrD3", "uri": "/contracts/43kgP0iVrD3#retained-rights", "label": "License Agreement (Imcor Pharmaceutical Co)", "score": 21.0, "published": true}, {"hash": "joGALZP1c5V", "uri": "/contracts/joGALZP1c5V#retained-rights", "label": "License Agreement (Techniclone Corp/De/)", "score": 18.0, "published": true}, {"hash": "eW2g5y5hlya", "uri": "/contracts/eW2g5y5hlya#retained-rights", "label": "Joint Collaboration and License Agreement (GTX Inc /De/)", "score": 18.0, "published": true}], "hash": "bebd360fcba8152fa396ee43c20ec4dd", "id": 3}, {"snippet_links": [{"key": "proper-attribution", "type": "clause", "offset": [40, 58]}, {"key": "patents-and-trademarks", "type": "clause", "offset": [71, 93]}], "snippet": "The Authors understand that they retain proper attribution and credit, patents and trademarks for published article.", "size": 44, "samples": [{"hash": "zBfwEG8U4S", "uri": "/contracts/zBfwEG8U4S#retained-rights", "label": "Journal Article Publishing Agreement", "score": 24.4798088074, "published": true}, {"hash": "sYRyRcWF9s", "uri": "/contracts/sYRyRcWF9s#retained-rights", "label": "Journal Article Publishing Agreement", "score": 24.4798088074, "published": true}, {"hash": "mTAnmrm6Gj", "uri": "/contracts/mTAnmrm6Gj#retained-rights", "label": "Journal Article Publishing Agreement", "score": 24.4798088074, "published": true}], "hash": "015becd13a5be7b5d6366e1472ee8ace", "id": 4}, {"snippet_links": [{"key": "section-68", "type": "clause", "offset": [16, 27]}, {"key": "other-rights", "type": "definition", "offset": [102, 114]}, {"key": "from-third-parties", "type": "clause", "offset": [115, 133]}, {"key": "in-order-to", "type": "clause", "offset": [155, 166]}, {"key": "exercise-of", "type": "clause", "offset": [198, 209]}, {"key": "rights-under-this-agreement", "type": "clause", "offset": [214, 241]}], "snippet": "Nothing in this Section 6.8 shall prevent Licensee, at its own expense, from obtaining any license or other rights from Third Parties it deems appropriate in order to permit the full and unhindered exercise of its rights under this Agreement.", "size": 18, "samples": [{"hash": "ixNwZX1Bmqj", "uri": "/contracts/ixNwZX1Bmqj#retained-rights", "label": "License and Development Agreement (Novadel Pharma Inc)", "score": 18.0, "published": true}, {"hash": "hIa6pmXBWR9", "uri": "/contracts/hIa6pmXBWR9#retained-rights", "label": "License and Development Agreement (Manhattan Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "9eorkb3gkl2", "uri": "/contracts/9eorkb3gkl2#retained-rights", "label": "License and Development Agreement (Novadel Pharma Inc)", "score": 18.0, "published": true}], "hash": "d34b48b8ba2255e3ff4e2956ecf32c0c", "id": 9}, {"snippet_links": [{"key": "scope-of-negotiations", "type": "clause", "offset": [59, 80]}, {"key": "government-code", "type": "clause", "offset": [84, 99]}, {"key": "provisions-of-this-agreement", "type": "clause", "offset": [144, 172]}, {"key": "statutory-provision", "type": "clause", "offset": [188, 207]}, {"key": "it-is-agreed-that", "type": "clause", "offset": [239, 256]}, {"key": "right-and-power", "type": "clause", "offset": [271, 286]}, {"key": "to-determine", "type": "definition", "offset": [287, 299]}, {"key": "structure-of-the", "type": "clause", "offset": [490, 506]}, {"key": "chain-of-command", "type": "clause", "offset": [531, 547]}, {"key": "and-committees", "type": "clause", "offset": [648, 662]}, {"key": "financial-structure", "type": "clause", "offset": [675, 694]}, {"key": "financial-support", "type": "definition", "offset": [749, 766]}, {"key": "incidental-to", "type": "definition", "offset": [844, 857]}, {"key": "compliance-with", "type": "definition", "offset": [890, 905]}, {"key": "funding-sources", "type": "definition", "offset": [962, 977]}, {"key": "condition-of", "type": "clause", "offset": [983, 995]}, {"key": "receiving-funds", "type": "clause", "offset": [996, 1011]}, {"key": "policies-and-practices", "type": "clause", "offset": [1028, 1050]}, {"key": "budgetary-matters", "type": "clause", "offset": [1056, 1073]}, {"key": "budget-calendar", "type": "definition", "offset": [1104, 1119]}, {"key": "accounting-methods", "type": "definition", "offset": [1151, 1169]}, {"key": "budget-control", "type": "clause", "offset": [1182, 1196]}, {"key": "policies-and-procedures", "type": "clause", "offset": [1197, 1220]}, {"key": "fund-provisions", "type": "clause", "offset": [1320, 1335]}, {"key": "the-acquisition", "type": "clause", "offset": [1362, 1377]}, {"key": "all-facilities", "type": "clause", "offset": [1519, 1533]}, {"key": "parking-areas", "type": "definition", "offset": [1544, 1557]}, {"key": "other-improvements", "type": "clause", "offset": [1563, 1581]}, {"key": "services-to-be-rendered", "type": "clause", "offset": [1679, 1702]}, {"key": "to-the-public", "type": "definition", "offset": [1703, 1716]}, {"key": "district-personnel", "type": "clause", "offset": [1724, 1742]}, {"key": "services-rendered", "type": "clause", "offset": [1761, 1778]}, {"key": "the-nature", "type": "clause", "offset": [1798, 1808]}, {"key": "standards-of-services", "type": "clause", "offset": [1852, 1873]}, {"key": "and-tools", "type": "clause", "offset": [1957, 1966]}, {"key": "in-connection-with", "type": "clause", "offset": [1978, 1996]}, {"key": "subcontracting-of-services", "type": "clause", "offset": [2023, 2049]}, {"key": "functions-to-be-performed", "type": "clause", "offset": [2069, 2094]}, {"key": "repair-service", "type": "clause", "offset": [2158, 2172]}, {"key": "periods-of-time", "type": "clause", "offset": [2210, 2225]}, {"key": "not-covered-by-this-agreement", "type": "clause", "offset": [2240, 2269]}, {"key": "not-limited", "type": "clause", "offset": [2286, 2297]}, {"key": "article-2", "type": "clause", "offset": [2360, 2369]}, {"key": "employees-covered", "type": "clause", "offset": [2426, 2443]}, {"key": "all-personnel", "type": "clause", "offset": [2582, 2595]}, {"key": "termination-of", "type": "clause", "offset": [2643, 2657]}, {"key": "assignment-of-employees", "type": "clause", "offset": [2693, 2716]}, {"key": "subject-matters", "type": "clause", "offset": [2806, 2821]}, {"key": "subject-only", "type": "definition", "offset": [2856, 2868]}, {"key": "article-6", "type": "clause", "offset": [2890, 2899]}, {"key": "the-determination", "type": "clause", "offset": [2919, 2936]}, {"key": "job-opening", "type": "clause", "offset": [2979, 2990]}, {"key": "job-classification", "type": "definition", "offset": [3047, 3065]}, {"key": "the-content", "type": "clause", "offset": [3070, 3081]}, {"key": "pay-for", "type": "clause", "offset": [3119, 3126]}, {"key": "new-classifications", "type": "clause", "offset": [3131, 3150]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [3174, 3197]}, {"key": "standards-of-performance", "type": "definition", "offset": [3221, 3245]}, {"key": "for-all-employees", "type": "clause", "offset": [3246, 3263]}, {"key": "any-employee", "type": "clause", "offset": [3277, 3289]}, {"key": "article-4", "type": "clause", "offset": [3381, 3390]}, {"key": "evaluation-procedures", "type": "clause", "offset": [3393, 3414]}, {"key": "operation-of", "type": "clause", "offset": [3455, 3467]}, {"key": "district-facilities", "type": "definition", "offset": [3468, 3487]}, {"key": "work-schedules", "type": "definition", "offset": [3516, 3530]}, {"key": "the-college", "type": "clause", "offset": [3532, 3543]}, {"key": "instructional-calendar", "type": "clause", "offset": [3546, 3568]}, {"key": "work-days", "type": "clause", "offset": [3593, 3602]}, {"key": "work-year", "type": "clause", "offset": [3631, 3640]}, {"key": "assignment-of-overtime", "type": "clause", "offset": [3646, 3668]}, {"key": "article-11", "type": "clause", "offset": [3703, 3713]}, {"key": "article-3", "type": "clause", "offset": [3728, 3737]}, {"key": "hours-of-employment", "type": "definition", "offset": [3740, 3759]}, {"key": "safety-and-security-measures", "type": "clause", "offset": [3770, 3798]}, {"key": "for-students", "type": "clause", "offset": [3799, 3811]}, {"key": "supplies-and-equipment", "type": "definition", "offset": [3881, 3903]}, {"key": "with-respect-to", "type": "clause", "offset": [3962, 3977]}, {"key": "article-5", "type": "clause", "offset": [4026, 4035]}, {"key": "safety-conditions-of-employment", "type": "definition", "offset": [4038, 4069]}, {"key": "retirement-of-employees", "type": "clause", "offset": [4084, 4107]}, {"key": "for-disability", "type": "clause", "offset": [4108, 4122]}, {"key": "provisions-of-law", "type": "clause", "offset": [4138, 4155]}, {"key": "layoff-of-employees", "type": "clause", "offset": [4191, 4210]}, {"key": "rights-enumerated", "type": "clause", "offset": [4256, 4273]}, {"key": "exercise-of", "type": "clause", "offset": [4303, 4314]}, {"key": "rights-of-the-district", "type": "clause", "offset": [4326, 4348]}, {"key": "language-of-this-agreement", "type": "clause", "offset": [4387, 4413]}, {"key": "rights-of-management", "type": "definition", "offset": [4430, 4450]}, {"key": "express-provisions", "type": "clause", "offset": [4612, 4630]}, {"key": "contractual-limitations", "type": "clause", "offset": [4669, 4692]}, {"key": "the-non", "type": "clause", "offset": [4806, 4813]}, {"key": "waiver-of-the", "type": "clause", "offset": [4864, 4877]}, {"key": "arising-out-of", "type": "definition", "offset": [4986, 5000]}, {"key": "such-rights", "type": "definition", "offset": [5274, 5285]}, {"key": "grievance-provisions", "type": "clause", "offset": [5309, 5329]}, {"key": "article-10", "type": "clause", "offset": [5343, 5353]}], "snippet": "18.1 All matters not specifically enumerated as within the scope of negotiations in Government Code, Section 3543.2 and specifically limited by provisions of this agreement, or limited by statutory provision, are reserved to the District. It is agreed that such reserved right and power to determine, implement, supplement, change, modify, or discontinue, in whole or in part, temporarily or permanently, any of the following:\n18.1.1 The legal, operational, geographical, or organizational structure of the District, including the chain of command, division and subdivisions, external and internal boundaries of all kinds, and advisory commissions and committees;\n18.1.2 The financial structure of the District, including all sources and amounts of financial support, income, funding, taxes, and debt, and all means and conditions necessary or incidental to the securing of same, including compliance with any qualifications or requirements imposed by law or by funding sources as a condition of receiving funds; all investment policies and practices, all budgetary matters and procedures, including the budget calendar, the budget formation process, accounting methods, fiscal and budget control policies and procedures, and all budgetary allocations, reserves, and expenditures apart from those expressly allocated to fund provisions of this agreement;\n18.1.3 The acquisition, disposition, number, location, types, and utilization of all District properties, whether owned, leased, or otherwise controlled, including all facilities, grounds, parking areas, and other improvements; and the personnel, work, service and activity functions assigned to such properties;\n18.1.4 All services to be rendered to the public and to District personnel in support of the services rendered to the public, and the nature, methods, quality, quantity, frequency and standards of services, and the personnel, facilities, vendors, supplies, materials, vehicles, equipment, and tools to be used in connection with such services, the lawful subcontracting of services to be rendered and functions to be performed including educational, support, construction, maintenance, and repair service;\n18.1.5 The utilization, for limited periods of time, of personnel not covered by this agreement, including, but not limited to, the personnel occupying positions listed as \u201cexcluded\u201d in Article 2 of this agreement, to do work which is normally done by employees covered hereby, and the methods of selection and assignments of such personnel;\n18.1.6 The selection, classification, direction, and promotion of all personnel in the District; the demotion, discipline, and termination of all personnel of the District; the assignment of employees to any location, and also to any facilities, classrooms, functions, activities, academic subject matters, departments, tasks or equipment (subject only to the provisions of Article 6, \u201cTransfers\u201d); and the determination as to whether, when, and where there is a job opening subject only to the provisions of Article 6;\n18.1.7 The job classification and the content qualifications thereof; the rates of pay for any new classifications implemented during the terms of this agreement;\n18.1.8 The duties and standards of performance for all employees, and whether any employee adequately performs such duties and meets such standards subject only to the provisions of Article 4, \u201cEvaluation Procedures\u201d;\n18.1.9 The dates, times, and hours of operation of District facilities, functions, and activities; work schedules; the college's instructional calendar; the assignment of paid work days beyond the regular assigned work year; the assignment of overtime subject only to the provisions of Article 11, \u201cWages\u201d; and Article 3, \u201cHours of Employment\u201d;\n18.1.10 Safety and security measures for students, employees, the public, properties, facilities, vehicles, materials, supplies and equipment, including the various rules and duties for all personnel with respect to such matters, subject only to the provisions of Article 5, \u201cSafety Conditions of Employment\u201d;\n18.1.11 The retirement of employees for disability, as limited by provisions of law;\n18.1.12 The lawful termination or layoff of employees as the result of the exercises of any of the rights enumerated above, or as a result of the exercise of any of the rights of the District not limited by the clear and explicit language of this agreement.\n18.2 All other rights of management not expressly limited by the clear and explicit language of this agreement are also expressly reserved to the District even though not enumerated above; and the express provisions of this agreement constitute the only contractual limitations upon the District's rights. The exercise of any right reserved to the District herein in a particular manner, or the non-exercise of any such right, shall not be deemed a waiver of the District's right or preclude the District from exercising the right in a different manner.\n18.3 Any dispute arising out of, or in any way connected with, either the existence of, or the exercise of, any of the rights of the District not expressly limited by the clear and explicit language of this agreement, or arising out of, or in any way connected with, the effects of the exercise of any of such rights, is not subject to the grievance provisions set forth in Article 10.", "size": 33, "samples": [{"hash": "iJNPkynkeOR", "uri": "/contracts/iJNPkynkeOR#retained-rights", "label": "Collective Bargaining Agreement", "score": 29.9532241821, "published": true}, {"hash": "gHeiU64Wvyt", "uri": "/contracts/gHeiU64Wvyt#retained-rights", "label": "Collective Bargaining Agreement", "score": 29.2286815643, "published": true}, {"hash": "kNiZWh7SFi3", "uri": "/contracts/kNiZWh7SFi3#retained-rights", "label": "Collective Bargaining Agreement", "score": 27.7737121582, "published": true}], "hash": "f523c5d4e2542b5e298b8b2fab1dec1d", "id": 7}, {"snippet_links": [{"key": "rights-and-licenses", "type": "clause", "offset": [15, 34]}, {"key": "when-effective", "type": "clause", "offset": [70, 84]}, {"key": "no-license-or-other-rights", "type": "clause", "offset": [87, 113]}, {"key": "to-licensee", "type": "definition", "offset": [126, 137]}, {"key": "property-of-licensor", "type": "clause", "offset": [161, 181]}, {"key": "licensed-technology", "type": "definition", "offset": [303, 322]}, {"key": "notwithstanding-anything-to-the-contrary", "type": "clause", "offset": [324, 364]}, {"key": "in-this-agreement", "type": "clause", "offset": [365, 382]}, {"key": "other-purposes", "type": "clause", "offset": [496, 510]}, {"key": "outside-of-the-field", "type": "clause", "offset": [512, 532]}, {"key": "without-limiting-the-foregoing", "type": "clause", "offset": [534, 564]}, {"key": "agreement-to", "type": "definition", "offset": [603, 615]}, {"key": "licensee-acknowledges", "type": "clause", "offset": [630, 651]}, {"key": "agrees-to", "type": "clause", "offset": [656, 665]}, {"key": "rights-retained-by-licensor", "type": "clause", "offset": [680, 707]}, {"key": "direct-and-indirect", "type": "clause", "offset": [716, 735]}, {"key": "outside-the-field", "type": "clause", "offset": [820, 837]}, {"key": "licenses-granted", "type": "clause", "offset": [860, 876]}, {"key": "offer-to-sell", "type": "clause", "offset": [1130, 1143]}, {"key": "domain-antibodies", "type": "clause", "offset": [1156, 1173]}, {"key": "with-respect-to", "type": "clause", "offset": [1305, 1320]}, {"key": "a-non", "type": "clause", "offset": [1350, 1355]}, {"key": "import-products", "type": "definition", "offset": [1467, 1482]}, {"key": "exclusive-right", "type": "clause", "offset": [1581, 1596]}, {"key": "for-licensor", "type": "clause", "offset": [1597, 1609]}, {"key": "for-non", "type": "clause", "offset": [1722, 1729]}, {"key": "research-purposes", "type": "clause", "offset": [1741, 1758]}, {"key": "research-efforts", "type": "clause", "offset": [1824, 1840]}, {"key": "licensor-retains", "type": "clause", "offset": [2002, 2018]}, {"key": "offer-for-sale", "type": "definition", "offset": [2180, 2194]}, {"key": "treatment-of", "type": "definition", "offset": [2224, 2236]}, {"key": "muscular-dystrophy", "type": "clause", "offset": [2432, 2450]}, {"key": "heart-failure", "type": "definition", "offset": [2468, 2481]}, {"key": "delivery-of", "type": "clause", "offset": [2572, 2583]}, {"key": "right-to-make", "type": "clause", "offset": [2804, 2817]}, {"key": "subject-of", "type": "clause", "offset": [2940, 2950]}, {"key": "one-claim", "type": "clause", "offset": [2960, 2969]}, {"key": "licensed-patents", "type": "clause", "offset": [2977, 2993]}, {"key": "cardiovascular-disease", "type": "definition", "offset": [3155, 3177]}, {"key": "to-the-extent", "type": "clause", "offset": [3264, 3277]}, {"key": "research-reagents", "type": "definition", "offset": [3858, 3875]}, {"key": "provided-that", "type": "clause", "offset": [3915, 3928]}, {"key": "for-clarity", "type": "clause", "offset": [3930, 3941]}, {"key": "such-rights", "type": "definition", "offset": [3943, 3954]}, {"key": "right-to-conduct", "type": "clause", "offset": [3998, 4014]}, {"key": "clinical-trials", "type": "definition", "offset": [4015, 4030]}, {"key": "in-the-field", "type": "clause", "offset": [4041, 4053]}, {"key": "to-provide-services", "type": "clause", "offset": [4093, 4112]}, {"key": "third-parties", "type": "clause", "offset": [4120, 4133]}, {"key": "licensed-products", "type": "clause", "offset": [4263, 4280]}], "snippet": "Except for the rights and licenses specified in Section 2.1.4 (if and when effective), no license or other rights are granted to Licensee under any intellectual property of Licensor, whether by implication, estoppel, or otherwise, whether any such intellectual property dominates or is dominated by the Licensed Technology. Notwithstanding anything to the contrary in this Agreement, Licensor may use and permit others to use the Licensed Technology for any research, development, commercial, or other purposes, outside of the Field. Without limiting the foregoing, and notwithstanding anything in this Agreement to the contrary, Licensee acknowledges and agrees to the following rights retained by Licensor and its direct and indirect licensors (individually and collectively, the \u201cRetained Rights\u201d), whether inside or outside the Field:\n2.2.1 The rights and licenses granted in Section 2.1.4 (if and when effective) shall not include any right (and Licensor and its direct and indirect licensors retain the exclusive (even as to Licensee), fully sublicensable right) under the Licensed Technology to make, have made, use, sell, offer to sell, and import Domain Antibodies that are expressed by an adeno-associated vector.\n2.2.2 Licensor and its direct and indirect licensors retain the following rights with respect to the Licensed Technology:\n(a) A non-exclusive, sublicensable right under the Licensed Technology to make, have made, use, sell, offer to sell, and import products that deliver RNA interference and antisense drugs using an adeno-associated vector; and\n(b) A non-exclusive right for Licensor\u2019s direct and indirect licensors (which right is sublicensable by such licensors) to use the Licensed Technology for non-commercial research purposes and to use the Licensed Technology for such licensors\u2019 discovery research efforts with non-profit organizations and collaborators.\n2.2.3 The rights and licenses granted in Section 2.1.4 (if and when effective) shall not include any right (and Licensor retains the exclusive (even as to Licensee), fully sublicensable right) under (a) the Licensed Technology that cover the rAAV serotype 8, to make, have made, use, sell, offer for sale, and import products for the treatment of all forms of hemophilia B; or (b) the Licensed Technology that cover the rAAV serotype 9, to make, have made, use, sell, offer for sale, and import products for the treatment of (i) all forms of Muscular Dystrophy; (ii) congestive heart failure suffered by Muscular Dystrophy patients; and (iii) any and all cardiovascular diseases by delivery of any or all of genes encoding I-lc and Serca2a and creatine kinase.\n2.2.4 Licensor and its direct and indirect licensors retain the following rights with respect to the Licensed Technology: a non-exclusive, sublicensable right to make, have made, use, sell, offer for sale, and import all of the various serotypes of any adeno-associated vector that is the subject of at least one claim in the Licensed Patents solely for non-commercial research in the areas of Muscular Dystrophy, hemophilia B, congestive heart failure suffered by Muscular Dystrophy patients, and other cardiovascular disease.\n2.2.5 Licensor retains the following rights with respect to the Licensed Technology: to the extent Licensed Technology pertains to recombinant adeno-associated virus serotype 8, an exclusive, sublicensable right to make, have made, use, sell, offer for sale, and import products for the treatment of hemophilia A.\n2.2.6 The rights and licenses granted in Section 2.1.4 (if and when effective) shall not include any right (and Licensor retains the exclusive (even as to Licensee), fully sublicensable right) under the Licensed Technology:\n(a) to conduct commercial reagent and services businesses, which includes the right to make, have made, use, sell, offer to sell, and import research reagents, including any viral vector construct; provided that, for clarity, such rights retained by Licensor shall not include the right to conduct clinical trials in humans in the Field; or\n(b) to use the Licensed Technology to provide services to any Third Parties; provided that, for clarity, Licensee\u2019s license under Section 2.1.4 (if and when effective) does include the right to administer Licensed Products to", "size": 32, "samples": [{"hash": "f1M45sRlJBh", "uri": "/contracts/f1M45sRlJBh#retained-rights", "label": "Option and License Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 29.1396312714, "published": true}, {"hash": "dR83dnXGKlD", "uri": "/contracts/dR83dnXGKlD#retained-rights", "label": "Option and License Agreement (Dimension Therapeutics, Inc.)", "score": 26.7796039581, "published": true}, {"hash": "hyvzU5OyK6Z", "uri": "/contracts/hyvzU5OyK6Z#retained-rights", "label": "Option and License Agreement (Dimension Therapeutics, Inc.)", "score": 26.7002048492, "published": true}], "hash": "035302259b37e804a744564920f8ec22", "id": 8}, {"snippet_links": [{"key": "nothing-in-this-agreement", "type": "clause", "offset": [58, 83]}, {"key": "obligation-to", "type": "clause", "offset": [173, 186]}, {"key": "your-right", "type": "clause", "offset": [225, 235]}, {"key": "cooperate-with", "type": "clause", "offset": [266, 280]}, {"key": "provide-information", "type": "clause", "offset": [282, 301]}, {"key": "participate-in", "type": "definition", "offset": [339, 353]}, {"key": "government-agency", "type": "clause", "offset": [377, 394]}, {"key": "not-limited", "type": "clause", "offset": [433, 444]}, {"key": "right-to-disclose", "type": "clause", "offset": [486, 503]}, {"key": "required-by-law", "type": "definition", "offset": [551, 566]}, {"key": "legal-process", "type": "definition", "offset": [570, 583]}, {"key": "the-release", "type": "clause", "offset": [594, 605]}, {"key": "to-the-maximum-extent-permitted-by-law", "type": "clause", "offset": [624, 662]}, {"key": "personal-relief", "type": "clause", "offset": [701, 716]}, {"key": "the-claims", "type": "clause", "offset": [728, 738]}, {"key": "paragraph-3", "type": "definition", "offset": [760, 771]}, {"key": "with-regard-to", "type": "clause", "offset": [772, 786]}, {"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [853, 882]}, {"key": "other-provision-of-this-agreement", "type": "clause", "offset": [891, 924]}, {"key": "local-law", "type": "clause", "offset": [1036, 1045]}, {"key": "governmental-agency", "type": "clause", "offset": [1078, 1097]}, {"key": "department-of-justice", "type": "definition", "offset": [1144, 1165]}, {"key": "inspector-general", "type": "clause", "offset": [1204, 1221]}, {"key": "taking-action", "type": "definition", "offset": [1236, 1249]}, {"key": "provisions-of", "type": "clause", "offset": [1315, 1328]}, {"key": "rule-21f-17", "type": "clause", "offset": [1418, 1429]}, {"key": "securities-exchange-act-of-1934", "type": "definition", "offset": [1452, 1483]}, {"key": "as-amended", "type": "definition", "offset": [1485, 1495]}, {"key": "reports-and-disclosures", "type": "clause", "offset": [1522, 1545]}, {"key": "prior-authorization", "type": "clause", "offset": [1600, 1619]}, {"key": "notification-to-the-company", "type": "clause", "offset": [1639, 1666]}, {"key": "right-to-receive", "type": "clause", "offset": [1727, 1743]}, {"key": "monetary-award", "type": "clause", "offset": [1746, 1760]}, {"key": "information-provided", "type": "clause", "offset": [1765, 1785]}, {"key": "pursuant-to-rule", "type": "clause", "offset": [1797, 1813]}, {"key": "disclosure-rights", "type": "clause", "offset": [2051, 2068]}, {"key": "the-employment-agreement", "type": "clause", "offset": [2088, 2112]}, {"key": "incorporated-by-reference", "type": "definition", "offset": [2129, 2154]}], "snippet": "(a) Regardless of whether or not you sign this Agreement, nothing in this Agreement is intended to or shall be interpreted to restrict or otherwise interfere with: (i) your obligation to testify truthfully in any forum; (ii) your right and/or obligation to contact, cooperate with, provide information to, file a charge with, or otherwise participate in any proceeding of, any government agency, commission or entity (including, but not limited, to the EEOC and the SEC); or (iii) your right to disclose any information or produce any documents as is required by law or legal process. However, the Release does prevent you, to the maximum extent permitted by law, from obtaining any monetary or other personal relief for any of the Claims you have released in Paragraph 3 with regard to any charge you may file or which may be filed on your behalf.\n(b) Notwithstanding the foregoing, or any other provision of this Agreement, nothing in this Agreement is intended to prohibit you from reporting possible violations of federal, state or local law, ordinance or regulation to any governmental agency or entity, including, but not limited to, the Department of Justice, the SEC, the Congress and any agency Inspector General, or otherwise taking action or making disclosures that are protected under the whistleblower provisions of any federal, state or local law, ordinance or regulation, including, but not limited to, Rule 21F-17 promulgated under the Securities Exchange Act of 1934, as amended. You are entitled to make reports and disclosures or otherwise take action under this paragraph without prior authorization from or subsequent notification to the Company. Similarly, nothing set forth in this Agreement limits your right to receive a monetary award for information provided to the SEC pursuant to Rule 21F-17 promulgated under the Securities Exchange Act of 1934, as amended, or for information provided to the DOL or any other government agency, commission or entity. Further, nothing set forth in this Agreement limits your immunity and disclosure rights in Section 8(e) of the Employment Agreement which is hereby incorporated by reference.", "size": 17, "samples": [{"hash": "eq83HorvU7d", "uri": "/contracts/eq83HorvU7d#retained-rights", "label": "Employment Agreement (Stonemor Partners Lp)", "score": 30.7138938904, "published": true}, {"hash": "dM0uhNNAV4l", "uri": "/contracts/dM0uhNNAV4l#retained-rights", "label": "Employment Agreement (Stonemor Partners Lp)", "score": 30.2867889404, "published": true}, {"hash": "1khqB02Q2N8", "uri": "/contracts/1khqB02Q2N8#retained-rights", "label": "Employment Agreement (Stonemor Partners Lp)", "score": 29.5393562317, "published": true}], "hash": "3a768c3058f56bbae18e03a64bedb503", "id": 10}, {"snippet_links": [{"key": "licensee-acknowledges", "type": "clause", "offset": [0, 21]}, {"key": "licenses-granted", "type": "clause", "offset": [31, 47]}, {"key": "pursuant-to-sections", "type": "clause", "offset": [48, 68]}, {"key": "this-agreement", "type": "clause", "offset": [84, 98]}, {"key": "right-to-grant-licenses", "type": "clause", "offset": [146, 169]}, {"key": "sole-discretion", "type": "definition", "offset": [234, 249]}, {"key": "additional-licenses", "type": "clause", "offset": [263, 282]}, {"key": "distribution-rights", "type": "definition", "offset": [286, 305]}, {"key": "licensed-product", "type": "clause", "offset": [339, 355]}, {"key": "to-third-parties", "type": "clause", "offset": [356, 372]}, {"key": "offer-for-sale", "type": "definition", "offset": [401, 415]}, {"key": "pharmaceutical-product", "type": "definition", "offset": [496, 518]}], "snippet": "Licensee acknowledges that the licenses granted pursuant to Sections 2.1 and 2.2 of this Agreement are non-exclusive and that (a) MPP retains the right to grant licenses to other MPP Licensees, and (b) Pfizer retains the right in its sole discretion to (i) grant additional licenses or distribution rights for the Compound, Product and/or Licensed Product to Third Parties and (ii) make, use, import, offer for sale, sell and/or donate the Compound, Product and/or Licensed Product (or any other pharmaceutical product containing the Compound or Product) on its own behalf.", "size": 38, "samples": [{"hash": "9UKSM6MoXOX", "uri": "/contracts/9UKSM6MoXOX#retained-rights", "label": "License Agreement", "score": 33.493347168, "published": true}, {"hash": "8BTiZcAhKvm", "uri": "/contracts/8BTiZcAhKvm#retained-rights", "label": "License Agreement", "score": 33.2059211731, "published": true}, {"hash": "8Dy7Yg2U5Ry", "uri": "/contracts/8Dy7Yg2U5Ry#retained-rights", "label": "License Agreement", "score": 33.1785469055, "published": true}], "hash": "e5e2fa4138f9a4d43f4e49bf0419ab5d", "id": 5}, {"snippet_links": [{"key": "termination-of-this-agreement", "type": "clause", "offset": [0, 29]}, {"key": "by-either-party", "type": "clause", "offset": [30, 45]}, {"key": "obligations-owing", "type": "clause", "offset": [116, 133]}, {"key": "between-the-parties", "type": "clause", "offset": [134, 153]}, {"key": "referred-account", "type": "definition", "offset": [164, 180]}, {"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [182, 211]}, {"key": "termination-for-cause", "type": "definition", "offset": [216, 237]}, {"key": "agency-shall", "type": "clause", "offset": [239, 251]}, {"key": "right-to-receive", "type": "clause", "offset": [263, 279]}, {"key": "contingent-fee", "type": "clause", "offset": [284, 298]}, {"key": "paying-accounts", "type": "definition", "offset": [302, 317]}, {"key": "insurance-accounts", "type": "definition", "offset": [332, 350]}, {"key": "right-to-recover", "type": "clause", "offset": [380, 396]}, {"key": "court-costs", "type": "clause", "offset": [401, 412]}], "snippet": "Termination of this Agreement by either Party will not affect the collection enforcement or validity of any accrued obligations owing between the Parties as to any Referred Account. Notwithstanding the foregoing and termination for cause, Agency shall retain the right to receive the Contingent Fee on paying accounts, settlements, insurance accounts or judgments, as well as the right to recover any court costs advanced on said accounts.", "size": 33, "samples": [{"hash": "6bvknsu20Oy", "uri": "/contracts/6bvknsu20Oy#retained-rights", "label": "Collections Services Agreement", "score": 30.7077217102, "published": true}, {"hash": "jTlzmLKIT4I", "uri": "/contracts/jTlzmLKIT4I#retained-rights", "label": "Collection Agency Agreement (CURO Group Holdings Corp.)", "score": 26.811088562, "published": true}, {"hash": "cgSwCvqBdtx", "uri": "/contracts/cgSwCvqBdtx#retained-rights", "label": "Collection Agency Agreement (CURO Group Holdings Corp.)", "score": 26.811088562, "published": true}], "hash": "905f5c830ad4ae0847f67f113da0f233", "id": 6}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhhyZXRhaW5lZC1yaWdodHMjMDAwMDAwMGEMogECZW4YACAA", "clause": {"title": "Retained Rights", "parents": [["grant-of-rights", "Grant of Rights"], ["license-grant", "License Grant"], ["grant", "Grant"], ["licenses", "Licenses"], ["license-grants", "License Grants"]], "size": 2644, "children": [["federal-government", "Federal Government"], ["other-organizations", "Other Organizations"], ["research-and-educational-use", "Research and Educational Use"], ["university", "University"], ["medical-school", "Medical School"]], "id": "retained-rights", "related": [["licensed-rights", "Licensed Rights", "Licensed Rights"], ["acquired-rights", "Acquired Rights", "Acquired Rights"], ["reserved-rights", "Reserved Rights", "Reserved Rights"], ["vested-rights", "Vested Rights", "Vested Rights"], ["protected-rights", "Protected Rights", "Protected Rights"]], "related_snippets": [], "updated": "2026-11-05T04:24:04+00:00", "also_ask": ["What minimum rights must be expressly retained to protect the client\u2019s core interests?", "How can retained rights be leveraged in negotiations to maximize future flexibility or revenue?", "What are the most common drafting pitfalls that undermine enforceability of retained rights?", "How do retained rights clauses differ across jurisdictions or industry standards?", "What legal tests do courts apply to determine the scope and validity of retained rights?"], "drafting_tip": "Specify the rights retained, clarify their limitations, and reference applicable law to prevent ambiguity, avoid overreach, and ensure enforceability.", "explanation": "The Retained Rights clause defines which rights a party keeps for itself, even after granting certain rights to another party under an agreement. Typically, this clause clarifies that the original owner of intellectual property or other assets does not transfer all rights, but instead retains specific uses or controls, such as the right to use the property for internal purposes or to license it to others. Its core function is to prevent misunderstandings by clearly outlining the boundaries of what is being transferred versus what remains with the original owner, thereby protecting their ongoing interests and avoiding unintended loss of rights."}, "json": true, "cursor": ""}}